Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG43048

CCDC71 Knockout Hela Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Uterus (cervix)

  • Disease:

    Adenocarcinoma

The CCDC71 Knockout HeLa Polyclonal Cells provide a CRISPR/Cas9-edited polyclonal population with disruption of the CCDC71 gene in HeLa human cervical adenocarcinoma cells. This loss-of-function model targets a coiled-coil domain protein predicted to localize to cilia and facilitate ciliogenesis and Hedgehog signaling, possibly interacting with IFT particles and the BBSome. Suitable for investigating ciliary biology and cervical cancer mechanisms, these cells support assays such as immunofluorescence, co-immunoprecipitation, and cell proliferation studies. The polyclonal format offers a heterogeneous system ideal for examining CCDC71??s scaffold functions and its potential role in oncogenic signaling networks.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HeLa

    Sex of Donor

    Female

    Age

    31 years

    Gene Name

    CCDC71

    Gene Identifier

    NCBI Gene ID 64925

    Morphology

    Epithelial-like

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    MEM (with NEAA)

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The CCDC71 Knockout HeLa Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population targeting the CCDC71 gene in the HeLa human cervical adenocarcinoma cell line. This product serves as a loss-of-function model for studying CCDC71, a coiled-coil domain-containing protein predicted to function in ciliogenesis and protein scaffolding. The polyclonal format yields a heterogeneous knockout pool, enabling population-level analyses while avoiding clonal artifacts. The CRISPR/Cas9-mediated gene disruption creates a versatile tool to dissect the poorly characterized roles of CCDC71. Researchers can employ these cells to investigate ciliary assembly and signaling in an immortalized epithelial context.

HeLa cells are an immortalized human cervical adenocarcinoma line originally derived from a patient??s tumor; they are HPV18-positive and exhibit robust epithelial morphology. This widely used cell line offers high transfectability and rapid proliferation, making it a staple in cancer biology and molecular cell research. While HeLa cells are not typically classified as ciliated under standard culture conditions, they retain the genetic machinery to assemble primary cilia upon serum deprivation or specific induction, rendering them suitable for ciliogenesis assays. Their cervical adenocarcinoma origin further positions them as a relevant model for studying oncogenic signaling pathways, including those modulated by ciliary proteins.

CCDC71 encodes a coiled-coil domain-containing protein predicted to localize to primary cilia, facilitating protein-protein interactions essential for ciliogenesis and Hedgehog signaling. It may scaffold components such as SMO and GLI transcription factors downstream of the Hedgehog pathway. Direct interactions remain unknown, but CCDC71 is predicted to associate with IFT particles and the BBSome complex, critical for ciliary trafficking. Upstream regulators may include ciliogenic transcription factors RFX and FOXJ1. Disruption of CCDC71 enables dissection of its contributions to cilia-dependent signaling and potential crosstalk with oncogenic pathways in cervical cancer.

In HeLa cells, CCDC71 knockout permits analysis of how loss of this ciliary scaffold affects cervical adenocarcinoma behavior. HeLa cells exhibit aberrant Hedgehog pathway activity that promotes proliferation and survival; deleting CCDC71 allows assessment of ciliary Hedgehog signaling and tumorigenic properties. The polyclonal population mirrors tumor microenvironment heterogeneity, enabling study of CCDC71??s role in cilia-related networks and their impact on cancer phenotypes. This model bridges ciliogenesis research and cervical cancer biology, offering a platform to elucidate ciliary dysfunction in oncogenesis.

Typical applications include ciliogenesis assays using serum starvation to induce cilia formation, followed by immunofluorescence microscopy to examine ciliary length and composition. Co-immunoprecipitation and western blotting can probe protein interactions and signaling changes, while RT-qPCR enables transcriptional profiling of Hedgehog target genes such as GLI1. Cell proliferation assays evaluate functional consequences on growth. The polyclonal nature of this knockout product is well suited for pooled screening approaches to identify genetic or pharmacological modifiers of CCDC71-dependent phenotypes. For additional information or to inquire about related products and custom services, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)